Tactile Systems Technology, Inc. - Common Stock (TCMD)
13.33
+0.14 (1.06%)
NASDAQ · Last Trade: Apr 7th, 7:39 PM EDT
Via Benzinga · March 13, 2025

Via Benzinga · February 19, 2025

Via Benzinga · November 26, 2024

Via Benzinga · November 5, 2024

Via Benzinga · November 5, 2024

Via Benzinga · November 21, 2023

Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases.
Via Talk Markets · November 18, 2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023

Via Benzinga · November 5, 2024

TCMD stock results show that Tactile Systems Tech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024

Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.
Via InvestorPlace · June 27, 2024

TCMD stock results show that Tactile Systems Tech beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

A new AI model has identified these stocks as "millionaire makers." Here are the AI stock picks that could deliver life-changing returns.
Via InvestorPlace · April 12, 2024

The medical technology company announced light Q4 revenue and underwhelming forward guidance.
Via The Motley Fool · February 20, 2024

Although deep value stocks present incredible risks for prospective investors, they also command the potential to fly higher.
Via InvestorPlace · February 1, 2024

One of the hottest topics among members of Congress and investors has been the stock and options trading activity by several politicians.
Via Benzinga · January 3, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Via Benzinga · February 20, 2024

Sen. Tina Smith's (D-Minn.) controversial November investment yielded a 48% return within just two months.
Via Benzinga · December 28, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via Benzinga · November 7, 2023

Via Benzinga · November 7, 2023

Via Benzinga · November 6, 2023

Via Benzinga · September 18, 2023